Form 4: Precigen Director Dean J. Mitchell Reports Stock Transaction
SEC Form 4 Filing
Director Dean J. Mitchell reports the vesting and conversion of restricted stock units into common stock of Precigen, Inc.
Summary
- On March 9, 2024, Dean J. Mitchell, a director of Precigen, Inc., reported a transaction involving restricted stock units (RSUs).
- The RSUs, representing a contingent right to receive one share of Precigen common stock each, vested in full on March 9, 2024.
- A total of 106,837 RSUs were converted into 106,837 shares of common stock.
- Following the transaction, Mitchell directly owns 463,673 shares of Precigen common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of a stock transaction. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider activity.
Positives
- The vesting of RSUs indicates that performance milestones, if any, were met.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction provides stakeholders with insight into the holdings of a key company director.
Key Dates
| Date | Description |
|---|---|
| 03/09/2024 | Date of transaction: RSUs vested and converted into common stock. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.